The University of California Berkeley Wellness Letter® and its Chair of the Editorial Board John Swartzberg, M.D., suggest “discouraging patients from taking drugs that have been on the market for less than three years unless there are no other options.” This allows time for new information to emerge on the effectiveness and safety of the new drugs.

Source: UC Berkeley Wellness Letter, January 2006.